Hyundai Motor Co will build a driving center in South Korea by 2022, featuring eight test courses that would provide various and dynamic driving experiences.
Thomas Schemera, executive vice president of Hyundai Motor, said that the driving center would become the epicenter of the country's expanding automobile culture with its performance-driving surfaces and topnotch facilities.
The driving center would be located inside the 1.26-square-kilometer tire-testing testing facility being built by Hankook Tire & Technology Co. in Taean.
Hyundai sold 217,510 vehicles in May, plummeting from 358,567 units a year before.
In the first five months of the year, sales dropped 26 percent to 1,288,629 units from 1,748,911 from the same period last year.
The project also serves to enhance the relations between the two companies.
Hyundai had recalled about 43,000 units of its 2015 Genesis premium sedan due to defects in the tires manufactured by Hankook.
Since then, Hyundai Motor Group had reduced its dependence on Hankook and turned to Goodyear, Michelin, Continental, Bridgestone, and Kumho.


Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer 



